RS

Radheshyam Sah

Active Director Director DIN 02584645
DIN 02584645 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Sep 2007
Shareholding value •••• Premium profile

About Radheshyam Sah

Data last updated:

Radheshyam Sah is a Director at Pashupati Chemicals & Pharmaceuticals Limited (since 2018), Director at Phyto Medicines Ltd (since 2007) and Director at Pashupati Promoters Limited (since 2022). The companies operate in Pharma, Trading and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹1.92 Cr; the largest is Pashupati Chemicals & Pharmaceuticals Limited at ₹1.87 Cr (FY 2024). Earlier, Radheshyam Sah was a Director at Psl Financial Services Ltd (2008–2013) and Additional Director at Pashupati Seohung Limited (2016–2020) and 1 more.

DIN 02584645
Primary Designation Director
Industry Pharma
First Appointment 28 Sep 2007
Oldest Company Age 42 yrs
Largest company Pashupati Chemicals & Pharmaceuticals Limited · ₹1.87 Cr (FY 2024)
Combined revenue ₹1.92 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20181984₹1.87 Cr (FY 2024)Active
Phyto Medicines Ltd U24231WB1989PLC046768
Director28 Sep 20071989₹3.8 Lakh (FY 2025)Active
Pashupati Promoters Limited U45400WB1989PLC047432
Director04 Jul 20221989₹41,710 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Psl Financial Services Ltd L65993WB1989PLC046140
Director30 Sep 20081989₹23.4 Lakh (FY 2019)Active
Pashupati Seohung Limited U25201WB1992PLC055223
Additional Director01 Apr 20161992₹2.18 Cr (FY 2023)Active
Saffy Healthcare Private Limited U36100WB1988PTC044862
Director30 Sep 20081988₹36,000 (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Radheshyam Sah

Directorship timeline

Open interactive timeline →
Pashupati Promoters Limited
Phyto Medicines Ltd
Pashupati Chemicals & Pharmaceuticals Limited
Psl Financial Services Ltd
Premium access

Shareholding and investment profile for Radheshyam Sah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radheshyam Sah

Radheshyam Sah currently holds 3 directorships: Pashupati Chemicals & Pharmaceuticals Limited (Director, since 25 Jul 2018, revenue ₹1.87 Cr (FY 2024)); Phyto Medicines Ltd (Director, since 28 Sep 2007, revenue ₹3.8 Lakh (FY 2025)); Pashupati Promoters Limited (Director, since 04 Jul 2022, revenue ₹41,710 (FY 2024)).

Radheshyam Sah was first appointed on 28 Sep 2007 as Director at Phyto Medicines Ltd. The most recent appointment on record is 04 Jul 2022 at Pashupati Promoters Limited.

The 3 current companies of Radheshyam Sah that report revenue have a combined latest revenue of ₹1.92 Cr: Pashupati Chemicals & Pharmaceuticals Limited ₹1.87 Cr (FY 2024); Phyto Medicines Ltd ₹3.8 Lakh (FY 2025); Pashupati Promoters Limited ₹41,710 (FY 2024).

Radheshyam Sah held 3 earlier board appointments: Psl Financial Services Ltd (Director, 30 Sep 2008 to 27 May 2013); Pashupati Seohung Limited (Additional Director, 01 Apr 2016 to 22 Oct 2020); Saffy Healthcare Private Limited (Director, 30 Sep 2008 to 04 Jun 2016).

The current boards of Radheshyam Sah's companies include Murari Lal Murarka (Pashupati Chemicals & Pharmaceuticals Limited), Rita Murarka (Pashupati Chemicals & Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available